Skip to main content

Foundation Medicine Raises Additional $13.5M in Series B Round

NEW YORK (GenomeWeb News) — Foundation Medicine said today that it has raised an additional $13.5 million in its Series B round of financing, bringing the total raised in the round to $56 million.

The company raised $42.5 million in the first closing of the round in September.

New investors include Bill Gates, Evan Jones, and Yuri Milner, joining existing investors Deerfield Management Company, L.P., Casdin Capital, Redmile Group, Roche Venture Fund, WuXi Corporate Venture Fund, and Laboratory Corporation of America Holdings. Other investors in the company include Third Rock Ventures, Google Ventures, and Kleiner Perkins Caufield & Byers.

The company said that proceeds from the financing will allow it to expand its commercial operations and clinical trials, scale its laboratory capabilities, and develop new genomic profiling and information services.

The company also announced that Evan Jones will join its board of directors. Jones is the managing member of jVen Capital and previously was the co-founder, chairman, and CEO of Digene.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.